Hepatobiliary scintigraphy to predict postoperative liver failure after major liver resection; a multicenter cohort study in 547 patients

HPB (Oxford). 2023 Apr;25(4):417-424. doi: 10.1016/j.hpb.2022.12.005. Epub 2023 Jan 13.

Abstract

Background: This study aimed to analyze the predictive value of Hepatobiliary scintigraphy (HBS) for posthepatectomy liver failure (PHLF) after major liver resection with a comparison to assessment of liver volume in a multicenter cohort.

Methods: Patients who underwent liver resection after HBS were included from six centers. Remnant liver volume was calculated from CT images. PHLF was scored and graded according to the grade B/C ISGLS criteria.

Results: In 547 patients PHLF incidence was 10% (56/547) and 90-day mortality rate 8% (42/547). Overall predictive value of remnant liver function was 0.66 (0.58-0.74) and similar to that of remnant volume (0.63 (0.72). For biliary tumors, a function cut-off of 2.7%/min/m2 and 30% volume cut-off resulted in a PHLF rate 12% and 13%, respectively. While an 8.5%/min (4.5%/min/m2) function cut-off resulted in 7% PHLF for those with a function above the cutoff while a 40% volume cutoff still resulted in 14% PHLF rate. In the multivariable analyses for PHLF, liver function was predictive but liver volume was not.

Conclusion: The current study shows that preoperative liver function assessment using HBS is at least as predictive for PHLF as liver volume assessment, and likely has several advantages, particularly in the high-risk sub-group of biliary tumors.

Publication types

  • Multicenter Study

MeSH terms

  • Cohort Studies
  • Hepatectomy / adverse effects
  • Humans
  • Liver Failure* / diagnostic imaging
  • Liver Failure* / etiology
  • Liver Failure* / surgery
  • Liver Neoplasms* / complications
  • Liver Neoplasms* / diagnostic imaging
  • Liver Neoplasms* / surgery
  • Postoperative Complications / diagnostic imaging
  • Postoperative Complications / etiology
  • Postoperative Complications / surgery
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Retrospective Studies

Substances

  • Radiopharmaceuticals